微宏控股美股招股说明书(2022-07-01版)

424B3 1 prosupp2mvstdef14a20220701.htm 424B3 Filed pursuant to Rule 424(b)(3)Registration No. 333-258978PROSPECTUS SUPPLEMENT NO. 2(to Prospectus dated June 9, 2022)Microvast Holdings, Inc.321,460,085 Shares of Common Stock837,000 Warrants to Purchase Common StockThis prospectus supplement No. 2 updates, amends and supplements the prospectus dated June 9, 2022 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-258978). Capitalized terms used in this prospectus supplement and not otherwise defined herein have the meanings specified in the Prospectus.On July 1, 2022, we filed the attached definitive proxy statement on Schedule 14A and definitive additional materials with the Securities and Exchange Commission, which are incorporated into the Prospectus (except any portions that were furnished and not filed).This prospectus supplement is not complete without the Prospectus and may not be delivered or utilized except in connection with the Prospectus with respect to the securities described above, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus, as supplemented to date, and this prospectus supplement is qualified by reference thereto, except to the extent that the information in this prospectus supplement updates or supersedes the information contained in the Prospectus. Please keep this prospectus supplement with your Prospectus for future reference. You should read the Prospectus and all prospectus supplements or amendments carefully before you invest in our securities.Our common stock and warrants are traded on the Nasdaq Global Select Market (“Nasdaq”) under the symbols “MVST,” and “MVSTW”, respectively. On June 28, 2022, the closing price of our common stock was $2.27 per share, and the closing price of our warrants was $0.3107 per warrant.We are an “emerging growth company,” as that term is defined under the federal securities laws and, as such, are subject to certain reduced public company reporting requirements.Investing in our securities involves risks. See “Risk Factors” beginning on page 21 of the Prospectus to read about factors you should consider before buying our common stock or warrants.Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.The date of this prospectus supplement is June 27, 2022. UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, DC 20549SCHEDULE 14A(Rule 14a-101)SCHEDULE 14A INFORMATIONProxy Statement Pursuant to Section 14(a) ofthe Securities Exchange Act of 1934(Amendment No.)Filed by the Registrant☑Filed by a Party Other than the Registrant☐Check the appropriate box:☐Preliminary Proxy Statement☐Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))☑Definitive Proxy Statement☐Definitive Additional Materials☐Soliciting Material under §240.14a-12MICROVAST HOLDINGS, INC.(Name of Registrant as Specified in its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant)Payment of Filing Fee (Check all boxes that apply):☑No fee required☐Fee paid previously with preliminary materials☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11MICROVAST HOLDINGS, INC.12603 Southwest Freeway, Suite 210Stafford, Texas 77477NOTICE OF ANNUAL MEETING OF STOCKHOLDERS AND PROXY STATEMENTTo Be Held: Friday, August 12, 2022To the Stockholders of Microvast Holdings, Inc.:Notice is hereby given that the 2022 Annual Meeting of Stockholders (the "2022 Annual Meeting") of Microvast Holdings, Inc., a Delaware corporation (the "Company", "Microvast," "we," or "our"), will be held virtually on August 12, 2022, at 9:00 a.m. Central Time for the following purposes, as more fully described in the accompanying proxy statement (the "Proxy Statement"):1)To elect two Class I director nominees to the Board of Directors, each to serve for a term of three years;2)To ratify the appointment of Deloitte Touche Tohmatsu Certified Public Accountants LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022; and3)To transact such other business that may properly come before the 2022 Annual Meeting and any continuation, postponement or adjournment thereof. The 2022 Annual Meeting will be held virtually over the Internet at: https://www.cstproxy.com/microvast/2022. You will not be able to attend the 2022 Annual Meeting in person.We are pleased to utilize the United States Securities and Exchange Commission's "notice and access" rules. Accordingly, we are providing stockhol